Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nanae Sugasaki
Observed name:
N. Sugasaki
Institutions:
Nagasaki University Hospital,
Nagasaki University,
Japanese Red Cross Nagasaki Genbaku Isahaya Hospital
Observed institutions:
Nagasaki University Hospital,
Nagasaki University,
Japanese Red Cross Nagasaki Genbaku Isahaya Hospital
OpenAlex ID:
A5025473586
Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations
2016
·
Kosuke Mizoguchi
, Yoichi Nakamura
, et al.
·
Cancer Chemotherapy and Pharmacology
·
18
Nivolumab plus ipilimumab with chemotherapy for non–small cell lung cancer with untreated brain metastases: A multicenter single-arm phase 2 trial (NIke, LOGiK 2004)
2024
·
Yuko Tsuchiya-Kawano
, Yoshimasa Shiraishi
, et al.
·
European Journal of Cancer
·
16
PDF
Phase II study of ramucirumab and docetaxel for previously platinum-treated patients with non-small cell lung cancer and malignant pleural effusion (PLEURAM study)
2024
·
Shinnosuke Takemoto
, Minoru Fukuda
, et al.
·
Translational Lung Cancer Research
·
5
Automated immunoassay of serum NY-ESO-1 and XAGE1 antibodies for predicting clinical benefit with immune checkpoint inhibitor (ICI) in advanced non-small cell lung cancer
2024
·
Kanako Sakaeda
, Koji Kurose
, et al.
·
Cancer Treatment and Research Communications
·
4
Phase II study of nedaplatin and amrubicin as first‐line treatment for advanced squamous cell lung cancer
2019
·
Hirokazu Taniguchi
, Hiroyuki Yamaguchi
, et al.
·
Thoracic Cancer
·
4
PDF
Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use
2019
·
Susumu Fukahori
, Tetsuya Kawano
, et al.
·
American Journal of Case Reports
·
3
PDF
A phase II clinical trial on the efficacy and safety of carboplatin plus nab-paclitaxel in chemotherapy-naive advanced or recurrent thymic epithelial tumors: protocol of Nab-TET
2025
·
Fumiko Hayashi
, Midori Matsuo
, et al.
·
Journal of Thoracic Disease
·
2
Pulmonary Nocardiosis Caused by Nocardia sputorum Identified via 16S rRNA Gene Sequencing: A Case Report
2024
·
Satoshi Irifune
, Shotaro Ide
, et al.
·
Cureus
·
1
PDF
MA15.10 Phase II Study of Nivolumab Plus Ipilimumab with Chemotherapy for Advanced NSCLC with Untreated Brain Metastases: NIke Trial (LOGiK2004)
2023
·
Y. Tsuchiya-Kawano
, Y. Shiraishi
, et al.
·
Journal of Thoracic Oncology
·
1
PDF
Phase II study of IRInotecan treatment after COmbined chemo‐immunotherapy for extensive‐stage small cell lung cancer: Protocol of IRICO study
2023
·
Hiromi Tomono
, Hirokazu Taniguchi
, et al.
·
Thoracic Cancer
·
1
PDF
Efficacy of S‐1 after pemetrexed in patients with non‐small cell lung cancer: A retrospective multi‐institutional analysis
2021
·
Shinnosuke Takemoto
, Kazumasa Akagi
, et al.
·
Thoracic Cancer
·
1
Exploratory study to evaluate the combined effect of CBM588: Clostridium butyricum in platinum plus pemetrexed with pembrolizumab for non-small cell lung cancer—protocol of MIYABRO study
2026
·
Ryuta Tagawa
, Hirokazu Taniguchi
, et al.
·
Translational Lung Cancer Research
Abstract A61: Development of automated immunoassay to detect serum biomarkers predicting response to immune checkpoint inhibitors in NSCLC
2022
·
Kanako Sakaeda
, Koji Kurose
, et al.
·
Cancer Immunology Research
316P Phase II study of ramucirumab and docetaxel for platinum-resistance NSCLC patients with malignant pleural effusion: Analysis of pleural effusion control rate
2022
·
R. Ogata
, S. Takemoto
, et al.
·
Annals of Oncology
EP08.04-005 Phase II Study of Ramucirumab and Docetaxel for NSCLC Patients with Malignant Pleural Effusion
2022
·
S. Takemoto
, M. Fukuda
, et al.
·
Journal of Thoracic Oncology
PDF
Efficacy of S-1 after pemetrexed in patients with non-small cell lung carcinoma: a retrospective multi-institutional analysis
2021
·
Shinnosuke Takemoto
, Kazumasa Akagi
, et al.
·
Research Square
PDF
Efficacy of S-1 after Pemetrexed in Patients with Non-small Cell Carcinoma: A Retrospective Multi-institutional Analysis
2020
·
Shinnosuke Takemoto
, Kazumasa Akagi
, et al.
·
Research Square
PDF
Phase I study of amrubicin and cisplatin with concurrent thoracic radiotherapy (TRT) in limited-disease small cell lung cancer (LD-SCLC).
2017
·
Midori Shimada
, Katsumi Nakatomi
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
18
Citation count:
56
H-index:
4
I10-index:
2
Year
Topic
Type